Oncolytics Biotech
ONCY
#9131
Rank
โ‚ฌ90.24 M
Marketcap
0,84ย โ‚ฌ
Share price
-4.80%
Change (1 day)
44.91%
Change (1 year)

Earnings for Oncolytics Biotech (ONCY)

Earnings in 2025 (TTM): -โ‚ฌ22.18 Million

According to Oncolytics Biotech 's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -โ‚ฌ22.2 Million a decrease over its 2023 earnings that were of -โ‚ฌ21.97 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Oncolytics Biotech from 2001 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚ฌ22.18 Million-0.08%
2024 -โ‚ฌ22.2 Million1.01%
2023 -โ‚ฌ21.97 Million23.39%
2022 -โ‚ฌ17.81 Million-1.98%
2021 -โ‚ฌ18.17 Million9.1%
2020 -โ‚ฌ16.65 Million22.64%
2019 -โ‚ฌ13.58 Million22.78%
2018 -โ‚ฌ11.06 Million4.1%
2017 -โ‚ฌ10.63 Million4.87%
2016 -โ‚ฌ10.13 Million8.75%
2015 -โ‚ฌ9.32 Million-37.06%
2014 -โ‚ฌ14.8 Million-26.2%
2013 -โ‚ฌ20.05 Million-37.39%
2012 -โ‚ฌ32.03 Million28.8%
2011 -โ‚ฌ24.87 Million46.02%
2010 -โ‚ฌ17.03 Million35.64%
2009 -โ‚ฌ12.56 Million-14.2%
2008 -โ‚ฌ14.63 Million-0.52%
2007 -โ‚ฌ14.71 Million24.6%
2006 -โ‚ฌ11.81 Million45.34%
2005 -โ‚ฌ8.13 Million-11.8%
2004 -โ‚ฌ9.21 Million115.36%
2003 -โ‚ฌ4.28 Million13.86%
2002 -โ‚ฌ3.76 Million-5.45%
2001 -โ‚ฌ3.98 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Eli Lilly
LLY
โ‚ฌ19.62 B-90,559.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ7.00 B-32,390.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Mirati Therapeutics
MRTX
-โ‚ฌ0.67 Billion 2,974.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Aeterna Zentaris
AEZS
-โ‚ฌ4.79 Million-77.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚ฌ1.87 B-8,750.56%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
AVEO Oncology
AVEO
-โ‚ฌ25.33 Million 16.73%๐Ÿ‡บ๐Ÿ‡ธ USA